İNSÜLİN DUYARLILIĞININ ARTTIRILMASINDA EGZERSİZİN VE BESLENMENİN ÖNEMİ

İnsülin duyarlılığı, glikoz metabolizmasını düzenleyen insülin hücrelerinin duyarlılık durumunu belirleyen ve çeşitli metobolik hastalıklar ve kanser gibi hastalıkların göstergesi olan bir terimdir. Sağlıklı yaşamak ve sağlıklı yaşlanmak için insülin duyarlılığı çok önemlidir. İnsülin normal büyüme ve gelişme, normal glukoz, yağ ve protein metabolizması için temel oluşturur. Yağ hariç her hangi bir gıdayı tüketildiğinde, kan şekeri yükselir buna bağlı olarak pankreastaki beta hücreleri insülin salgılar. Salgılanan insülin de glikozun hücre içine girmesinde anahtar görevi görür. Bu çalışmada, söz konusu sistemin çalışma metodu ve insan sağlığı üzerindeki önemi anlatılmaktadır.

Anahtar Kelimeler:

insülin duyarlılığı, insülin direnci, Egzersiz

THE IMPORTANCE OF EXERCISE AND NUTRITION FOR INCREASING INSULIN SENSITIVITY

Insulin sensitivity is a term that determines how sensitive insülin cells that regulate glucose metabolism and is indicative of diseasessuch as various metabolic diseases and cancer. Insulin sensitivity is very important for healthy living and healthy a ging. Insulin is essential for normal growth and development; and for normal homeostasis of glucose, fat and protein metabolism. When any food is consumed exceptfat, the blood sugarrises and the beta cells in the pancreas release insulin. These creted insülin acts as a key for glucose to enter the cell. In this study, the working method of this system and its importance on human health are explained.

PDF

___

1.Mayer-Davis EJ, Monaco JH, Hoen HM, et al.Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance At herosclerosis Study (IRAS). Am J ClinNutr 1997;65(1):79-87.
2.Thorell A, Hirshman MF, Nygren J, et al. Exercise and insülin cause GLUT-4 translocation in human skeletal muscle. Am J Physiol 1999;277(4):733-41.
3.Stumvoll M, NurjhanN , Perriello G, et al. Metaboliceffects of metformin in non-insülin dependent diabete smellitus. The New England Journal of Medicine 1995;333(9):550-4.
4.Fischer S, Bornstein SR. New oral antidiabetic agents—clinical perspectives. Internist (Berl) 2008;49(4):495-501.
5.Snitker S, Watanabe RM, Ani I, et al. Troglitazone in Prevention of Diabetes (TRIPOD) study. Changesin insülin sensitivity in response to troglitazonedo not differ between subjects with and without the common, functional Pro12Ala peroxis omepro liferator-activated receptor-gamma 2 genevariant: Results from the Troglitazone in Preventionof Diabetes (TRIPOD) study. Diabetes Care 2004;27(6):1365-8.
6.Gerstein HC, Yusuf S, Bosch J, et al. DREAM (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication) Trial Investigators: effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet 2006;368(9549):1096–105.
7.https://iubmb.onlinelibrary.wiley.com/doi/toc/10.1002/(ISSN)18728081(CAT)VirtualIssues(VI)NutritionVI (E.T. 26.09.2018).